Intensity Therapeutics INTS Income Statement (2022-2026)

NASDAQ INTS
$4.88 +0.68 (+16.19%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter) 0.14M0.14M0.14M0.14M0.14M0.55M0.34M0.55M0.55M0.55M0.60M0.61M0.75M1.96M1.36M2.54M2.95M
Operating items
Research & Development (Quarter) 1.39M1.16M0.89M0.77M0.86M1.35M1.80M2.81M3.56M2.15M1.97M2.19M1.54M1.55M1.50M1.20M1.83M
Selling, General & Administrative (Quarter) 0.54M0.61M0.58M0.48M0.36M1.14M1.55M1.93M1.51M1.42M1.24M1.21M1.16M1.18M1.64M1.33M1.25M
Operating Expenses (Quarter) 1.93M1.77M1.47M1.25M1.22M2.49M3.35M4.74M5.07M3.57M3.20M3.39M2.71M2.73M3.14M2.53M3.08M
Operating Income (Quarter) -1.93M-1.77M-1.47M-1.25M-1.22M-2.49M-3.35M-4.74M-5.07M-3.57M-3.20M-3.39M-2.71M-2.73M-3.14M-2.53M-3.08M
EBIT (Quarter) -1.93M-1.77M-1.47M-1.25M-1.22M-2.49M-3.35M-4.74M-5.07M-3.57M-3.20M-3.39M-2.71M-2.73M-3.14M-2.53M-3.08M
Non-operating items
Interest & Investment Income (Quarter) 213.00988.00156.000.15M0.18M0.14M0.10M0.05M0.03M0.01M0.02M0.06M0.09M0.09M0.08M
Other Non Operating Income (Quarter) 0.02M0.01M-0.05M0.00M0.00M2.29M0.01M-0.01M0.03M0.15M0.00M0.00M-0.00M
Net income details
EBT (Quarter) -1.94M-1.78M-1.51M-1.34M-1.71M-2.43M-3.18M-4.61M-4.99M-3.54M-3.17M-3.40M-2.73M-2.81M-3.07M-2.54M-3.11M
Profit After Tax (Quarter) -1.93M-1.77M-1.51M-1.34M-3.70M-2.33M-3.17M-4.60M-4.97M-3.51M-3.18M-3.35M-2.54M-2.67M-3.01M-2.40M-3.01M
Income from Continuing Operations (Quarter) -1.94M-1.78M-1.51M-1.34M-1.71M-2.43M-3.18M-4.61M-4.99M-3.54M-3.17M-3.40M-2.73M-2.81M-3.07M-2.54M-3.11M
Consolidated Net Income (Quarter) -1.94M-1.78M-1.51M-1.34M-1.71M-2.43M-3.18M-4.61M-4.99M-3.54M-3.17M-3.40M-2.73M-2.81M-3.07M-2.54M-3.11M
Income towards Parent Company (Quarter) -1.94M-1.78M-1.51M-1.34M-1.71M-2.43M-3.18M-4.61M-4.99M-3.54M-3.17M-3.40M-2.73M-2.81M-3.07M-2.54M-3.11M
Preferred Dividend Payments (Quarter) 1.32M
Net Income towards Common Stockholders (Quarter) -1.93M-1.77M-1.51M-1.34M-5.03M-2.33M-3.17M-4.61M-4.97M-3.51M-3.18M-3.40M-2.73M-2.81M-3.07M-2.54M-3.11M
Additional items
EPS (Basic) (Quarter) -14.13-13.01-11.07-9.80-35.72-4.26-9.20-8.40-9.06-6.36-5.72-5.60-3.61-1.63-2.26-1.00-1.15
EPS (Diluted) (Quarter) -14.13-13.01-11.07-9.80-35.72-4.26-9.20-8.40-9.06-6.36-5.72-5.60-3.61-1.63-2.26-1.00-1.15
Shares Outstanding (Quarter) 0.14M0.14M0.14M0.14M0.14M0.55M0.34M0.55M0.55M0.55M0.56M0.61M0.75M1.72M1.36M2.53M2.71M
Shares Outstanding (Diluted) (Quarter) 0.14M0.14M0.14M0.14M0.14M0.55M0.34M0.55M0.55M0.55M0.56M0.61M0.75M1.72M1.36M2.53M2.71M
EBITDA (Quarter) -1.93M-1.77M-1.47M-1.25M-1.22M-2.49M-3.35M-4.74M-5.07M-3.57M-3.20M-3.39M-2.71M-2.73M-3.14M-2.53M-3.08M
Interest Expenses (Quarter) 0.01M0.02M0.04M0.08M0.49M0.09M0.00M0.02M0.02M-0.00M0.02M0.04M0.13M0.02M0.11M0.10M